HLN · Pharma and healthcare · one day
Haleon (HLN): news on Tuesday 3 November 2026
News from the 24 hours to Tuesday morning, 3 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage centred on Haleon lowering its guidance after a weak cold and flu season and a China setback, which sent the shares sharply lower. A broker downgrade added to the negative tone, only partly offset by a director share purchase and a Goldman Sachs conviction list addition.
What drove it
- guidance cut
- share price fall
- broker views
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Wed 28 Oct | +1.3 | 5 |
| Thu 29 Oct | +5.7 | 5 |
| Fri 30 Oct | −10.0 | 70 |
| Sat 31 Oct | −5.2 | 9 |
| Sun 1 Nov | −3.5 | 2 |
| Mon 2 Nov | −5.7 | 3 |
| Tue 3 Nov | −9.7 | 9 |
5 stories · 9 headlines · strongest first
Pharma and healthcare on 3 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Haleon lowers its 2026 growth outlook following soft third quarter −10.03 headlines today · 60 in all, since 30 October · Shares fell on weak flu medicine demand and a guidance cut after China setback. | ||
| −10.0 | Sharp share price drop was a leading market story | |
| −10.0 | Outlook lowered owing to weak flu season and China softness in quarter | |
| −10.0 | Share price fell as flu medicine demand disappointed | |
| Brokers change Haleon targets and ratings +0.22 headlines today · 6 in all, since 31 October · Berenberg cut Haleon and Goldman added stocks to its conviction list. | ||
| −9.2 | Broker lowered its view on the stock | |
| +7.5 | Broker added it to a high-conviction list of picks | |
| Haleon director buys shares +2.32 headlines today · A director bought 7,670 shares. | ||
| +2.5 | Director bought shares personally, a modest show of confidence | |
| +2.0 | Director dealing filing suggesting insider buying | |
| Nestlé Purina and Haleon execs discuss AI commerce +1.71 headline today · Executives from Nestlé Purina and Haleon talk about consumer control in commerce guided by AI. | ||
| +1.7 | Executives featured in industry discussion on AI-driven retail; mildly positive profile | |
| Haleon buyback commentary +0.81 headline today · A piece asks whether Haleon relies on buybacks. | ||
| +0.8 | Commentary on buybacks supporting value; broadly neutral | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Haleon: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.